(Q60641675)

English

Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: An investigator-originated compassionate-use experience

scientific article published on 01 September 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: an investigator-originated compassionate-use experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

ovarian carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Sandrine Faivre

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

S Kalla

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E Cvitkovic

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

O Bourdon

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Hauteville

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L M Dourte

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M A Bensmaïne

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Itzhaki

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Marty

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J M Extra

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 September 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1125-1128

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334215414

7 January 2021

based on heuristic

inferred from DOI database lookup

Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334215414

7 January 2021

based on heuristic

inferred from DOI database lookup

hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334215414

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of oxaliplatin in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334215414

7 January 2021

based on heuristic

inferred from DOI database lookup

Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334215414

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334215414

7 January 2021

based on heuristic

inferred from DOI database lookup

Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334215414

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose carboplatin and recombinant granulocyte-macrophage colony-stimulating factor in advanced-stage recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334215414

7 January 2021

based on heuristic

inferred from DOI database lookup

Second-line therapy with paclitaxel and carboplatin for recurrent disease following first-line therapy with paclitaxel and platinum in ovarian or peritoneal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334215414

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008334215414

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572615%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60641675&oldid=1946858790"